ACT-GLOBAL IA Thrombolysis(ACT-REACT-004)Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632

Clinical trial NCT07687056 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07687056
Sponsor: University of Calgary
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Stroke, Acute Ischemic Endovascular Thrombectomy Acute Ischemic Stroke AIS

Start date: 2026-06-10
Primary completion: 2030-12-31
Enrollment: 1500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.